Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 65.93%325.1M | 163.79%451.08M | 39.81%422.81M | 26.92%1.03B | 122.88%359.63M | 32.38%195.92M | -16.29%171M | 1.80%302.42M | -55.77%810.7M | -70.70%161.35M |
| Net income from continuing operations | -138.99%-455.84M | -120.26%-53.15M | -25.77%110.82M | 486.33%371.39M | 156.16%150.47M | -543.70%-190.73M | 1,111.13%262.36M | 39.35%149.3M | -110.06%-96.13M | -182.71%-267.92M |
| Operating gains losses | -142.05%-43.02M | 165.12%153.32M | -13.63%38.26M | -248.43%-63.14M | -117.10%-15.18M | 468.37%102.32M | -926.03%-235.45M | -38.59%44.3M | 108.61%42.54M | 146.29%88.75M |
| Depreciation and amortization | 8.33%185.61M | 6.61%181.73M | 2.20%172.1M | 3.23%673.73M | -4.44%163.53M | 5.51%171.34M | 6.39%170.46M | 5.99%168.39M | 4.47%652.62M | 6.55%171.13M |
| Asset impairment expenditure | --526.53M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --163.17M | ---- |
| Unrealized gains and losses of investment securities | 39.49%140.15M | ---- | ---- | -69.17%93.7M | -105.15%-9.8M | 118.10%100.48M | ---- | ---- | --303.9M | --190.2M |
| Deferred tax | -373.30%-134.85M | -448.16%-48.59M | -75.71%1.82M | 94.38%-5.87M | 101.14%1.2M | -264.95%-28.49M | -27.05%13.96M | 167.54%7.47M | -203.10%-104.43M | -1,440.68%-104.69M |
| Other non cashItems | -13.04%78.63M | 12.73%83.19M | -49.08%59.99M | -8.84%264.25M | -79.38%26.1M | 181.84%90.43M | -9.31%73.8M | 136.45%117.8M | -18.48%289.86M | 2.55%126.58M |
| Change In working capital | 156.46%27.9M | 217.92%134.57M | 121.55%39.83M | 30.79%-305.08M | 121.04%43.31M | 50.55%-49.42M | -106.86%-114.12M | -131.48%-184.85M | -252.08%-440.83M | -245.75%-205.87M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 65.93%325.1M | 163.79%451.08M | 39.81%422.81M | 26.92%1.03B | 122.88%359.63M | 32.38%195.92M | -16.29%171M | 1.80%302.42M | -55.77%810.7M | -70.70%161.35M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -964.59%-28.74M | 87.77%-19.01M | 97.15%-10.4M | 61.64%-448.81M | -82.84%74.01M | 99.68%-2.7M | 44.80%-155.41M | 24.78%-364.71M | -85.82%-1.17B | 238.30%431.26M |
| Net PPE purchase and sale | 35.14%-34.74M | 89.02%-26.98M | 89.47%-22.18M | -25.19%-552.22M | 72.44%-42.38M | 26.84%-53.55M | -63.67%-245.59M | -228.72%-210.69M | 2.53%-441.11M | -5.88%-153.76M |
| Net intangibles purchas and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 98.51%-1.05M | ---- |
| Net business purchase and sale | --0 | --0 | --0 | 134.72%175.15M | -91.75%42.07M | --0 | 215.43%215.18M | 81.08%-82.1M | -211.59%-504.5M | 546.80%510.12M |
| Net other investing changes | -88.22%5.99M | 106.37%7.97M | 116.39%11.78M | 67.89%-71.74M | -2.16%74.32M | 113.84%50.85M | -327.54%-124.99M | -647.50%-71.92M | -503.55%-223.39M | 319.12%75.95M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -964.59%-28.74M | 87.77%-19.01M | 97.15%-10.4M | 61.64%-448.81M | -82.84%74.01M | 99.68%-2.7M | 44.80%-155.41M | 24.78%-364.71M | -85.82%-1.17B | 238.30%431.26M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 43.21%-200.94M | -1,454.21%-529.74M | -1,702.79%-212.45M | -183.30%-720.25M | 44.01%-418.83M | -174.88%-353.79M | -72.61%39.12M | 108.92%13.26M | 57.97%-254.24M | -42.13%-748.05M |
| Net issuance payments of debt | 110.76%25.24M | -265.10%-342.06M | -155.08%-78.27M | -132.13%-109.14M | 47.48%-223.96M | -146.55%-234.47M | -28.12%207.18M | 648.10%142.11M | 148.73%339.65M | 5.95%-426.41M |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -95.20%40.91M | -100.17%-337K |
| Cash dividends paid | -54.22%-79.83M | -55.36%-79.84M | 1.19%-52.09M | 2.14%-206.65M | 4.74%-50.78M | 3.55%-51.76M | 2.43%-51.39M | -2.30%-52.72M | -1.50%-211.18M | 1.80%-53.31M |
| Interest paid (cash flow from financing activities) | -21.59%-67.36M | -0.86%-106.33M | 3.09%-54.15M | -6.12%-345.78M | 9.66%-129.09M | -0.93%-55.4M | -22.87%-105.42M | -32.20%-55.88M | 3.13%-325.84M | -22.40%-142.89M |
| Net other financing activities | -549.44%-78.99M | 86.60%-1.51M | -37.96%-27.95M | 39.99%-58.67M | 88.01%-15M | -115.79%-12.16M | -61.61%-11.25M | 70.98%-20.26M | -4.59%-97.78M | -811.22%-125.1M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 43.21%-200.94M | -1,454.21%-529.74M | -1,702.79%-212.45M | -183.30%-720.25M | 44.01%-418.83M | -174.88%-353.79M | -72.61%39.12M | 108.92%13.26M | 57.97%-254.24M | -42.13%-748.05M |
| Net cash flow | ||||||||||
| Beginning cash position | -1.63%737.51M | 18.63%827.66M | -17.15%613.32M | -45.74%740.24M | -30.39%596.23M | -30.10%749.7M | -33.94%697.66M | -40.08%740.24M | 102.51%1.36B | -44.16%856.53M |
| Current changes in cash | 159.43%95.42M | -278.54%-97.67M | 507.75%199.96M | 77.17%-140.09M | 109.53%14.81M | 25.11%-160.57M | -16.57%54.71M | 85.42%-49.04M | -202.53%-613.59M | 45.93%-155.44M |
| Effect of exchange rate changes | 30.75%9.29M | 381.57%7.52M | 122.60%14.38M | 225.73%13.17M | -94.20%2.27M | 568.54%7.1M | 94.57%-2.67M | 504.30%6.46M | -137.84%-10.47M | -26.65%39.15M |
| End cash Position | 41.26%842.21M | -1.63%737.51M | 18.63%827.66M | -17.15%613.32M | -17.15%613.32M | -30.39%596.23M | -30.10%749.7M | -22.49%697.66M | -43.05%740.24M | -43.05%740.24M |
| Free cash from | 103.95%290.37M | 668.53%424.1M | 336.77%400.63M | 29.36%476.75M | 4,746.50%317.25M | 90.32%142.37M | -237.58%-74.6M | -60.63%91.73M | -71.86%368.54M | -98.05%6.55M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.